Mohta Srikant, Rajput Mahendra S, Ahuja Vineet, Makharia Govind K
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
J Neurogastroenterol Motil. 2021 Jul 30;27(3):337-346. doi: 10.5056/jnm20140.
Celiac disease (CeD) is a systemic, immune-mediated enteropathy, which is triggered by gluten protein in genetically susceptible individuals. CeD, once thought to be an uncommon disease, is now recognized to affect approximately 40-60 million people globally. While CeD is now well reported from a few Asian countries such as India, China, Pakistan, and Middle Eastern countries; it is still believed to be uncommon in the rest of Asia. Gluten-related diseases other than CeD, like non-celiac gluten sensitivity (NCGS) are also emerging globally. CeD and NCGS may present with either intestinal or extra-intestinal symptoms, and a proportion of them have overlapping symptoms with irritable bowel syndrome. Hence, many of them are misdiagnosed as having irritable bowel syndrome in clinical practice. In this review, we discuss the emergence of CeD and other gluten-related disorders, both globally and in Asia, the overlapping manifestations between gluten-related disorders and irritable bowel syndrome, and the challenges associated with diagnosis and management of CeD in Asia.
乳糜泻(CeD)是一种全身性、免疫介导的肠病,由遗传易感个体中的麸质蛋白引发。CeD曾被认为是一种罕见疾病,如今全球约有4000万至6000万人受其影响。虽然CeD在印度、中国、巴基斯坦等一些亚洲国家以及中东国家已有充分报道,但在亚洲其他地区仍被认为较为罕见。除CeD外,麸质相关疾病,如非乳糜泻麸质敏感(NCGS)在全球范围内也日益凸显。CeD和NCGS可能表现为肠道或肠道外症状,其中一部分与肠易激综合征有重叠症状。因此,在临床实践中,许多此类患者被误诊为患有肠易激综合征。在本综述中,我们讨论了CeD和其他麸质相关疾病在全球及亚洲的出现情况、麸质相关疾病与肠易激综合征之间的重叠表现,以及亚洲CeD诊断和管理所面临的挑战。